{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:53:42Z","timestamp":1771541622651,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jaci.2019.12.914","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T19:25:45Z","timestamp":1579289145000},"page":"780-781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunologic dysfunction and Hodgkin lymphoma: Insight to better therapy?"],"prefix":"10.1016","volume":"145","author":[{"given":"Brian K.","family":"Link","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2019.12.914_bib1","doi-asserted-by":"crossref","first-page":"l4450","DOI":"10.1136\/bmj.l4450","article-title":"HPV vaccine: high coverage could eradicate cervical cancer within decades, say researchers","volume":"365","author":"Torjesen","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jaci.2019.12.914_bib2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1634\/theoncologist.11-6-590","article-title":"Cancer in 15- to 29-year-olds by primary site","volume":"11","author":"Bleyer","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.jaci.2019.12.914_bib3","series-title":"Precision molecular biology of Hodgkin lymphoma","article-title":"The epidemiology of Hodgkin lymphoma","author":"Cozen","year":"2018"},{"key":"10.1016\/j.jaci.2019.12.914_bib4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2019.10.033","article-title":"Allergic disease, corticosteroid use, and risk of Hodgkin\u2019s lymphoma: a\u00a0UK nationwide case-control study","volume":"145","author":"Rafiq","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2019.12.914_bib5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00125-017-4518-6","article-title":"Promises and pitfalls of electronic health record analysis","volume":"61","author":"Farmer","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaci.2019.12.914_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.seminhematol.2016.05.003","article-title":"Prognostic factors in Hodgkin lymphoma","volume":"53","author":"Brockelmann","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jaci.2019.12.914_bib8","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/HS9.0000000000000020","article-title":"Immune checkpoint inhibition in Hodgkin lymphoma","volume":"2","author":"Moy","year":"2018","journal-title":"HemaSphere"},{"key":"10.1016\/j.jaci.2019.12.914_bib9","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood-2018-04-843714","article-title":"Mass cytometry of Hodgkin lymphoma reveals a CD4(+) regulatory T-cell-rich and exhausted T-effector microenvironment","volume":"132","author":"Cader","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2019.12.914_bib10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/gepi.22242","article-title":"Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes","volume":"43","author":"Din","year":"2019","journal-title":"Genet Epidemiol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920300440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920300440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:23:14Z","timestamp":1758792194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920300440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0091674920300440"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2019.12.914","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunologic dysfunction and Hodgkin lymphoma: Insight to better therapy?","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.12.914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2019.10.033","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}